Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]...
Sony Interactive Entertainment (NYSE: SNE) unveiled its next-gen PlayStation 5 console Thursday along with an impressive line of games.Both exclusive and third-party titles were highlighted during "The Future of Gaming" event. The responses to the PS5 have been positive, a good sign considering that a price point for both consoles have not been revealed.Primary, Digital PlayStation Console Could Boost Sales: The presentation primarily focused on the lineup of games for the PS5, but Sony also revealed two versions of the next-gen console: the PS5 and the PS5 Digital Edition. "We were somewhat surprised that Sony announced a digital version of the PS5 without an optical drive, in addition to the traditional model with an optical drive," BofA Securities analyst Mikio Hirakawa wrote in a note. BofA believes the market consensus estimate for the PS5 hardware price is $499. The addition of the digital console is expected to help boost sales by...
AstraZeneca Plc has signed a contract with European governments to supply the region with its potential vaccine against the coronavirus, the British drugmaker's latest deal to pledge its drug to help combat the pandemic. The contract is for up to 400 million doses of the vaccine, developed by the University of Oxford, the company said on Saturday, adding that it was looking to expand manufacturing of the vaccine, which it said it would provide for no profit during the pandemic. The deal is the first contract signed by Europe's Inclusive Vaccines Alliance (IVA), a group formed by France, Germany, Italy and the Netherlands to secure vaccine doses for all member states as soon as possible....
AstraZeneca Plc said on Saturday it signed a contract with European governments to supply the region with its potential vaccine against the coronavirus, the British drugmaker's latest deal to pledge its drug to help combat the pandemic. The contract is for up to 400 million doses of the vaccine, developed by the University of Oxford, the company said, adding that it was looking to expand manufacturing of the vaccine, which it said it would provide for no profit during the pandemic. The deal is the first contract signed by Europe's Inclusive Vaccines Alliance (IVA), a group formed by France, Germany, Italy and the Netherlands to secure vaccine doses for all member states as soon as possible....
British drugmaker AstraZeneca Plc said on Saturday it signed a contract with Italy, Germany, France and the Netherlands to supply Europe with a vaccine against the coronavirus, with deliveries starting by the end of 2020. The contract is for up to 400 million doses of the vaccine, developed by the University of Oxford, the company said, adding that it was looking to expand manufacturing of the vaccine, which it pledged to provide for no profit during the pandemic. The experimentation phase of the vaccine is already advanced and expected to end in the autumn, Italian Health Minister Roberto Speranza said in a Facebook post....
Italy, Germany, France and the Netherlands have signed a contract with Astrazeneca to supply European citizens with a vaccine against the coronavirus, Italy's health minister said on Saturday. The contract is for 400 million doses of the vaccine, which was developed with the University of Oxford and whose experimentation phase is already advanced and expected to end in autumn, Roberto Speranza said in a Facebook post....
